Case Report
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 108258
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.108258
Table 1 Demographic and clinical characteristics
Characteristics
n = 82
mean ± SD/percentage (%)
Age(years)8141.8 ± 13.2
ND1
Duration of Crohn’s disease (years)7219.3 ± 11.1
ND10
GenderMale5769.51
Female2530.49
History of prior intestinal surgeryYes3947.56
No4352.44
History of prior IBD therapyCorticosteroids4558.44
Aminosalicylate3950.65
Immunomodulators3545.45
Anti-TNF2127.27
Antibiotics11.29
ND5
SymptomAbdominal pain5688.89
Diarrhea2742.86
Nausea and vomiting2946.03
Anemia2133.33
Hematochezia1015.87
Weight loss2844.44
Fever23.17
Abdominal mass23.17
ND19
LocationTerminal ileum3444.74
Ileum3242.10
Jejunum79.21
Mid-small bowel33.95
ND6
ColonoscopyIndication of tumor538.46
No indication of tumor861.54
ND69
Tumor marker (CEA, CA19-9)Elevated428.57
Normal1071.43
ND68
Differentiation degreeLow differentiation1145.83
Moderate-low differentiation14.17
Moderate differentiation625
High differentiation625
ND58
T classificationTis12.33
112.33
236.98
31534.88
42353.48
ND39
N classificationYes2660.47
No1739.53
ND39
M classificationYes918.75
No3981.25
ND34